The New York Entrepreneur

Chemical giant Chemours delays quarterly earnings release, internal review underway

Read Time:8 Second

Chemours Co.’s stock dropped more than 4% in the extended session Tuesday after the chemicals company delayed its quarterly financial results, saying it “needs additional time.”

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Arm’s stock suffers its worst day on record as AI euphoria cools
Next post Jeff Bezos unloads another $2 billion of Amazon stock. He’s sold $4 billion this month.